Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia

Schizophrenia Research

Volumn 168, Issue 1-2, 2015, Pages 543-553

  Roberts, R C ^a   Barksdale, K A ^a,b   Roche, J K ^a   Lahti, A C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Armstrong State University   (United States)

Author keywords

Dopamine; Electron microscopy; Glutamate; Neuropathology; Psychosis

Indexed keywords

ANTERIOR CINGULATE; ARTICLE; AUTOPSY; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROANATOMY; NEUROPIL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SYNAPSE; ADULT; AGED; CINGULATE GYRUS; ELECTRON MICROSCOPY; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; ULTRASTRUCTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GYRUS CINGULI; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MITOCHONDRIA; SCHIZOPHRENIA; SYNAPSES;

EID: 84942369050     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.07.016     Document Type: Article

References (120)

1. Aganova E.A., Uranova N.A. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci. Behav. Physiol. 1992, 22(1):59-65.
2. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 1999, 156(10):1580-1589.
3. Alain C., McNeely H.E., He Y., Christensen B.K., West R. Neurophysiological evidence of error-monitoring deficits in patients with schizophrenia. Cereb. Cortex 2002, 12(8):840-846.
4. Anglin R.E., Mazurek M.F., Tarnopolsky M.A., Rosebush P.I. The mitochondrial genome and psychiatric illness. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012, 159B(7):749-759.
5. Bannister A.P. Inter- and intra-laminar connections of pyramidal cells in the neocortex. Neurosci. Res. 2005, 53(2):95-103.
6. Barch D.M., Braver T.S., Akbudak E., Conturo T., Ollinger J., Snyder A. Anterior cingulate cortex and response conflict: effects of response modality and processing domain. Cereb. Cortex 2001, 11(9):837-848.
7. Barksdale K.A., Roche J.K., Roberts R.C., Lahti A.C. Synaptic and mitochondrial changes in the anterior cingulate cortex in schizophrenia. Neuropsychopharmacology 2012, 38:S314-S446.
8. Barksdale K.A., Roche J.K., Lahti A.C., Roberts R.C. Synaptic and Mitochondrial Changes in the Postmortem Anterior Cingulate Cortex in Schizophrenia. Program No. 223.11. 2012 Neuroscience Meeting Planner 2012, Society for Neuroscience, New Orleans, LA.
9. Barksdale K.A., Lahti A.C., Roberts R.C. Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response. Neuropsychopharmacology 2014, 39(9):2095-2103.
10. Bates T.E., Strangward M., Keelan J., Davey G.P., Munro P.M., Clark J.B. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. NeuroReport 1996, 7(8):1397-1400.
11. Bauer D., Gupta D., Harotunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr. Res. 2008, 104(1-3):108-120.
12. Bauer D., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. Schizophr. Res. 2010, 117(1):92-98.
13. Benes F.M. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 2010, 35:239-257.
14. Benes F.M., Bird E.D. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch. Gen. Psychiatry 1987, 44(7):608-616.
15. Benes F.M., Majocha R., Bird E.D., Marotta C.A. Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch. Gen. Psychiatry 1987, 44(11):1017-1021.
16. Benes F.M., Sorensen I., Vincent S.L., Bird E.D., Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb. Cortex 1992, 2(6):503-512.
17. Benes F.M., Todtenkopf M.S., Taylor J.B. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 1997, 25(1):80-92.
18. Benes F.M., Vincent S.L., Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry 2001, 50(6):395-406.
19. Bolding M., Reid M., Avsar K., Roberts R., Gamlin P., Gawne T., White D., Lahti A. Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biol. Psychiatry 2013, 73(3):289-294.
20. Bouras C., Kövari E., Hof P.R., Riederer B.M., Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol. 2001, 102(4):373-379.
21. Braver T.S., Barch D.M., Gray J.R., Molfese D.L., Snyder A. Anterior cingulate cortex and response conflict: effects of frequency, inhibition and errors. Cereb. Cortex 2001, 11(9):825-836.
22. Brune M., Schobel A., Karau R., Benali A., Faustmann P.M., Juckel G., Petrasch-Parwez E. Von Economo neuron density in the anterior cingulate cortex is reduced in early onset schizophrenia. Acta Neuropathol. 2010, 119(6):771-778.
23. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 2000, 4(6):215-222.
24. Calhoun M.E., Jucker M., Martin L.J., Thinakaran G., Price D.L., Mouton P.R. Comparative evaluation of synaptophysin-based methods for quantification of synapses. J. Neurocytol. 1996, (12):821-828.
25. 2O PET study during single-trial Stroop task performance. Am. J. Psychiatry 1997, 154(12):1670-1675.
26. Carter C.S., MacDonald A.W., Ross L.L., Stenger V.A. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am. J. Psychiatry 2001, 158(9):1423-1428.
27. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 2001, 78(4):736-745.
28. Chang D.T., Reynolds I.J. Mitochondrial trafficking and morphology in healthy and injured neurons. Prog. Neurobiol. 2006, 80(5):241-268.
29. Cunningham M.G., Bhattacharyya S., Benes F.M. Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J. Comp. Neurol. 2002, 453:116-130.
30. DeFelipe J., Jones E.G. Parvalbumin immunoreactivity reveals layer IV of monkey cerebral cortex as a mosaic of microzones of thalamic afferent terminations. Brain Res. 1991, 562(1):39-47.
31. DeFelipe J., Alonso-Nanclares L., Arellano J.I. Microstructure of the neocortex: comparative aspects. J. Neurocytol. 2002, 31(3-5):299-316.
32. Del Rio M.R., DeFelipe J. A light and electron microscopic study of calbindin D-28k immunoreactive double bouquet cells in the human temporal cortex. Brain Res. 1995, 690:133-140.
33. Del Rio M.R., DeFelipe J. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J. Neurosci. 1997, 17(13):5143-5154.
34. Drummond J.B., Tucholski J., Haroutunian V., Meador-Woodruff J.H. Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia. Schizophr. Res. 2013, 147(1):32-38.
35. Duchen M.R., Verkhratsky A., Muallem S. Mitochondria and calcium in health and disease. Cell Calcium 2008, 44(1):1-5.
36. Dugan L.L., Sensi S.L., Canzoniero L.M., Handran S.D., Rothman S.M., Lin T.S., Goldberg M.P., Choi D.W. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 1995, (15):6377-6388.
37. Eastwood S.L., Harrison P.J. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res. Bull. 2001, 55(5):569-578.
38. Egerton A., Brugger S., Raffin M., Barker G.J., Lythgoe D.J., McGuire P.K., Stone J.M. Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology 2012, 37(11):2515-2521.
39. Fannon D., Simmons A., Tennakoon L., O'Ceallaigh S., Sumich A., Doku V., Shew C., Sharma T. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol. Psychiatry 2003, 54(6):587-598.
40. Fornito A., Yücel M., Dean B., Wood S.J., Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr. Bull. 2009, 35(5):973-993.
41. Fremeau R.T., Voglmaier S., Seal R.P., Edwards R.H. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci. 2004, 27(2):98-103.
42. Funk A.J., McCullumsmith R.E., Haroutunian V., Meador-Woodruff J.H. Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacology 2012, 37(4):896-905.
43. Funk A.J., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia. Schizophr. Res. 2014, 159(1):130-135.
44. Gaspar P., Berger B., Fabvret A., Vigny A., Henry J.P. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J. Comp. Neurol. 1989, (279):249-271.
45. Geinisman Y., Gunderson H.J.G., Van Der Zee E., West M.J. Unbiased stereological estimation of the total number of synapses in a brain region. J. Neurocytol. 1996, (12):805-819.
46. Giguere M., Goldman-Rakic P.S. Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J. Comp. Neurol. 1988, 277(2):195-213.
47. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57(1):65-73.
48. Goldman P.S., Nauta W.J. An intricately patterned prefronto-caudate projection in the rhesus monkey. J. Comp. Neurol. 1977, 72(3):369-386.
49. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. PNAS 2003, 100(1):253-258.
50. Gunter T.E., Gunter K.K., Sheu S.S., Gavin C.E. Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 1994, 267(2 Pt 1):C313-C339.
51. Heckers S., Weiss A.P., Deckersbach T., Goff D.C., Morecraft R.J., Bush G. Anterior cingulate cortex activation during cognitive interference in schizophrenia. Am. J. Psychiatry 2004, 161(4):707-715.
52. Hendry S.H., Jones E.G., Emson P.C. Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J. Neurosci. 1984, 4(10):2497-2517.
53. Hensch T.K. Critical period mechanisms in developing visual cortex. Curr. Top. Dev. Biol. 2005, 69:215-237.
54. Holcomb H.H., Lahti A.C., Medoff D.R., Weiler M., Dannals R.F., Tamminga C.A. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. Am. J. Psychiatry 2000, 157(10):1634-1645.
55. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 2009, 35(3):549-562.
56. Jessen F., Fingerhut N., Sprinkart A.M., Kühn K.U., Petrovsky N., Maier W., Schild H.H., Block W., Wagner M., Träber F. N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia. Schizophr. Bull. 2013, 39(1):197-205.
57. Jones E.G. A new view of specific and nonspecific thalamocortical connections. Adv. Neurol. 1998, (77):49-71. (Discussion 72-73).
58. Jones E.G., Hendry S.H. Differential calcium binding protein immunoreactivity distinguishes classes of relay neurons in monkey thalamic nuclei. Eur. J. Neurosci. 1989, 1(3):222-246.
59. Kalus P., Senitz D., Beckmann H. Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res. 1997, 75(1):49-59.
60. Kalus P., Senitz D., Lauer M., Beckmann H. Inhibitory cartridge synapses in the anterior cingulate cortex of schizophrenics. J. Neural Transm. 1999, 106(7-8):763-771.
61. Katsel P., Byne W., Roussos P., Tan W., Siever L., Haroutunian V. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology 2011, 36(6):1171-1177.
62. Kerns J.G., Cohen J.D., MacDonald A.W., Cho R.Y., Stenger V.A., Carter C.S. Anterior cingulate conflict monitoring and adjustments in control. Science 2004, 303(5660):1023-1026.
63. Kisvárday Z.F., Gulyas A., Beroukas D., North J.B., Chubb I.W., Somogyi P. Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex. Brain 1990, 113(3):793-812.
64. Kolomeets N.S., Orlovskaya D.D., Rachmanova V.I., Uranova N.A. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse 2005, 57(1):47-55.
65. Kolomeets N.S., Orlovskaya D.D., Uranova N.A. Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia. Synapse 2007, 61(8):615-621.
66. Kopp B., Rist F. An event-related brain potential substrate of disturbed response monitoring in paranoid schizophrenic patients. J. Abnorm. Psychol. 1999, 108(2):337-346.
67. Koski L., Petrides M. Time-related changes in task performance after lesions restricted to the frontal cortex. Neuropsychology 2001, 39(3):268-281.
68. Kraguljac N.V., Reid M.A., White D., Jones R., den Hollander J., Lowman D. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and metaanalysis. Psychiatry Res. 2012, 203(2-3):111-125.
69. Ledeen R.W., Wang J., Wu G., Lu Z.H., Chakraborty G., Meyenhofer M., Tyring S.K., Matalon R. Physiological role of N-acetylaspartate: contribution to myelinogenesis. Adv. Exp. Med. Biol. 2006, (76):131-143. (Discussion 361-363).
70. Lentz M.R., Kim J.P., Westmoreland S.V., Greco J.B., Fuller R.A., Ratai E.M., He J., Sehgal P.K., Halpern E.F., Lackner A.A., Masliah E., Gonzalez R.G. Quantitative neuropathologic correlates of changes in ratio of N-acetylaspartate to creatine in macaque brain. Radiology 2005, 235(2):461-468.
71. Lewis D.A., Foote S.L., Goldstein M., Morrison J.H. The dopaminergic innervation of the monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study. Brain Res. 1988, (449):225-243.
72. Lewis D.A., Melchitzky D.S., Burgos G.G. Specificity in the functional architecture of primate prefrontal cortex. J. Neurocytol. 2002, 31(3-5):265-276.
73. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119(6):873-887.
74. Lidow M.S., Song Z.M., Castner S.A., Allen P.B., Greengard P., Goldman-Rakic P.S. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biol. Psychiatry 2001, 49(1):1-12.
75. Ligon L.A., Steward O. Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons. J. Comp. Neurol. 2000, 427(3):351-361.
76. Manji H., Kato T., Di Prospero N.A., Ness S., Beal M.F., Krams M., Chen G. Impaired mitochondrial function in psychiatric disorders. Nat. Rev. Neurosci. 2012, 13(5):293-307.
77. Mathalon D.H., Fedor M., Faustman W.O., Gray M., Askari N., Ford J.M. Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J. Abnorm. Psychol. 2002, 111(1):22-41.
78. McCollum L.A., Walker C.K., Roche J.K., Roberts R.C. Elevated excitatory input to the nucleus accumbens in schizophrenia: a postmortem ultrastructural study. Schizophr. Bull. 2015, (in press).
79. Melchitzky D.S., Sesack S.R., Pucak M.L., Lewis D.A. Synaptic targets of pyramidal neurons providing intrinsic horizontal connections in monkey prefrontal cortex. J. Comp. Neurol. 1998, 390(2):211-224.
80. Melchitzky D.S., Eggan S.M., Lewis D.A. Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience 2005, 13(1):185-195. See comment in PubMed Commons below.
81. Miller K.E., Sheetz M.P. Axonal mitochondrial transport and potential are correlated. J. Cell Sci. 2004, 117(Pt 13):2791-2804.
82. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 2007, 81(2):89-131.
83. Morecraft R.J., Stilwell-Morecraft K.S., Cipolloni P.B., Ge J., McNeal D.W., Pandya D.N. Cytoarchitecture and cortical connections of the anterior cingulate and adjacent somatomotor fields in the rhesus monkey. Brain Res. Bull. 2012, 87(4-5):457-497.
84. Negyessy L., Goldman-Rakic P.S. Morphometric characterization of synapses in the primate prefrontal cortex formed by afferents from the mediodorsal thalamic nucleus. Exp. Brain Res. 2005, 164(2):148-154.
85. Nordahl T.E., Kusubov N., Carter C., Salamat S., Cummings A.M., O'Shora-Celaya L., Eberling J., Robertson L., Huesman R.H., Jagust W., Budinger T.F. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology 1996, 6:541-554.
86. Oni-Orisan A., Kristiansen L.V., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol. Psychiatry 2008, 63(8):766-775.
87. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry 1990, (47):1023-1028.
88. Palomero-Gallagher N., Mohlberg H., Zilles K., Vogt B. Cytology and receptor architecture of human anterior cingulate cortex. J. Comp. Neurol. 2008, 508(6):906-926.
89. Perez-Costas E., Melendez-Ferro M., Roberts R.C. Microscopy techniques and the study of synapses. Modern Research and Educational Topics in Microscopy 2007, 164-170. Formatex, Badajoz, Spain. A. Mendez-Vilas, J. Diaz (Eds.).
90. Peters A. Examining neocortical circuits: some background and facts. J. Neurocytol. 2002, 31(3-5):183-193.
91. Peterson B.S., Skudlarski P., Gatenby J.C., Zhang H., Anderson A.W., Gore J.C. An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biol. Psychiatry 1999, 45(10):1237-1258.
92. Reid M.A., Stoeckel L.E., White D.M., Avsar K.B., Bolding M.S., Akella N.S., Knowlton R.C., den Hollander J.A., Lahti A.C. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biol. Psychiatry 2010, 68(7):625-633.
93. Roberts R.C., Roche J.K., Conley R.R. Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia. Synapse 2008, 62(8):616-627.
94. Roberts R.C., Barksdale K., Roche J.K., Lahti A.C. Synaptic and mitochondrial changes in the anterior cingulate cortex in schizophrenia. International Congress on Schizophrenia Research Meeting. Schizophr. Bull. 2013, 39(Suppl. 1):16. (S203).
95. Roberts R.C., Roche J.K., McCullumsmith R.E. Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study. Neuroscience 2014, (277C):522-540.
96. Rowland L.M., Kontson K., West J., Edden R.A., Zhu H., Wijtenburg S.A., Holcomb H.H., Barker P.B. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr. Bull. 2013, 39(5):1096-1104.
97. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 1999, 45(1):17-25.
98. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J. Comp. Neurol. 1995, 363(2):264-280.
99. Shibata H. Efferent projections from the anterior thalamic nuclei to the cingulate cortex in the rat. J. Comp. Neurol. 1993, 330(4):533-542.
100. Smiley J.F., Williams S.M., Szigeti K., Goldman-Rakic P.S. Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J. Comp. Neurol. 1992, 321(3):325-335.
101. Somerville S.M., Lahti A.C., Conley R.R., Roberts R.C. Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response. Synapse 2011, 65(3):215-224.
102. Somerville S.M., Conley R.R., Roberts R.C. Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia. Synapse 2012, 66(1):29-41.
103. Steen R.G., Hamer R.M., Lieberman J.A. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005, 30(11):1949-1962.
104. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 2005, 10(10):900-919.
105. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397(6718):441-446.
106. Tamminga C.A., Thaker G.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., Carpenter W.T. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry 1992, 49(7):522-530.
107. Théberge J., Al-Semaan Y., Williamson P.C., Menon R.S., Neufeld R.W., Rajakumar N., Schaefer B., Densmore M., Drost D.J. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am. J. Psychiatry 2003, 160(12):2231-2233.
108. Todtenkopf M.S., Vincent S.L., Benes F.M. A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr. Res. 2005, 73(1):79-89.
109. Uranova N.A., Vostrikov V.M., Orlovskaya D.D., Rachmanova V.I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004, 67(2-3):269-275.
110. Uranova N.A., Vikhreva O.V., Zimina I.S., Rakhmanova V.I., Klintsova A., Black J., Greenough W.T., Orlovskaia D.D. Abnormal patterns of cortical synaptic connectivity in schizophrenia. Vestn. Ross. Akad. Med. Nauk 2007, (3):8-14.
111. Uranova N.A., Vikhreva O.V., Rachmanova V.I., Orlovskaya D.D. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr. Res. Treat. 2011, (1155):325789.
112. Vogt B.A., Pandya D.N. Cingulate cortex of the rhesus monkey: II. Cortical afferents. J. Comp. Neurol. 1987, 262(2):271-289.
113. Vogt B.A., Pandya D.N., Rosene D.L. Cingulate cortex of the rhesus monkey: I. Cytoarchitecture and thalamic afferents. J. Comp. Neurol. 1987, 262(2):256-270.
114. Vogt B.A., Finch D.M., Olson C.R. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb. Cortex 1992, 2(6):435-443.
115. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009, 11(5):523-529.
116. Williams S.M., Goldman-Rakic P.S. Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb. Cortex 1993, (3):199-222.
117. Wong-Riley M.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 1989, 12(3):94-101.
118. Woo T.U., Walsh J.P., Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 2004, (7):649-657.
119. Woo T.U., Shrestha K., Amstrong C., Minns M.M., Walsh J.P., Benes F.M. Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Schizophr. Res. 2007, 96(1-3):46-61.
120. Young K.A., Manaye K.F., Liang C., Hicks P.B., German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry 2000, 47(11):944-953.